These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 80260)

  • 21. Detection of inapparent nodule-transformed cells in the mammary gland tissues of virgin female BALB/cfC3H mice.
    DeOme KB; Miyamoto MJ; Osborn RC; Guzman RC; Lum K
    Cancer Res; 1978 Jul; 38(7):2103-11. PubMed ID: 207423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential response of cultured mouse mammary cells of varying tumorigenicity to cytochalasin B.
    Steiner MR; Altenburg B; Richards CS; Dudley JP; Medina D; Butel JS
    Cancer Res; 1978 Sep; 38(9):2719-21. PubMed ID: 679176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced production of mouse mammary tumor virus in dexamethasone-treated, 5-iododeoxyuridine-stimulated mammary tumor cell cultures.
    Fine DL; Plowman JK; Kelley SP; Arthur LO; Hillman EA
    J Natl Cancer Inst; 1974 Jun; 52(6):1881-6. PubMed ID: 4134501
    [No Abstract]   [Full Text] [Related]  

  • 25. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters.
    Paul RD; Ghaffar A; Sigel MM; Charyulu V; Lopez DM
    Anticancer Res; 1981; 1(2):63-9. PubMed ID: 6214206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
    Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

  • 28. Establishment and characterization of immortalized non-transplantable mouse mammary cell lines cloned from a MMTV-induced tumor cell line cultured for a long duration.
    Takenaka T; Saga S; Miyaishi O; Imai M; Yokoi T; Lu J; Wajjwalku W; Kusakabe M; Taguchi O; Matsuyama M
    Nagoya J Med Sci; 1991 Mar; 53(1-4):9-21. PubMed ID: 1666666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal but not carcinomatous primary rat mammary epithelium: readily transplanted to and maintained in the athymic nude mouse.
    Welsch CW; O'Connor DH; Aylsworth CF; Sheffield LG
    J Natl Cancer Inst; 1987 Mar; 78(3):557-65. PubMed ID: 3102827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone-responsive genes of the mouse mammary tumor virus.
    Svec J; Hlavay E; Matoska J; Thurzo V
    Czech Med; 1979; 2(4):198-212. PubMed ID: 94006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor.
    Miller FR; Heppner GH
    J Natl Cancer Inst; 1979 Dec; 63(6):1457-63. PubMed ID: 229294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of epidermal growth factor in implantation and growth of mouse mammary tumor in female nude mice.
    Tsutsumi O; Tsutsumi A; Oka T
    Cancer Res; 1987 Sep; 47(17):4651-3. PubMed ID: 3497710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD; Padmanabhan R; Lopez DM
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conditions for hormone-stimulated expression of endogenous C57Bl strain-associated mammary tumor virus genome.
    Svec J; Hlavayová E; Matoska J; Thurzo V
    Neoplasma; 1979; 26(5):539-50. PubMed ID: 230421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of tumor-specific immunity against antigens unrelated to the mammary tumor virus in spontaneous mammary adenocarcinomas.
    Morton DL; Miller GF; Wood DA
    J Natl Cancer Inst; 1969 Feb; 42(2):289-301. PubMed ID: 4303881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.